Fig. 4From: European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramateRisk of bias ratings for the randomized controlled trials of topiramate vs. placebo included in this meta-analysisBack to article page